.INVESTIGATION HIGHLIGHT.19 September 2024. Plozasiran reduced triglyceride amounts through 80% and also decreased the danger of pancreatitis in individuals with relentless chylomicronemia, along with or even without a genetic medical diagnosis.
Harmonizing information on world news, finance, technology, health, and lifestyle for a balanced view.
.INVESTIGATION HIGHLIGHT.19 September 2024. Plozasiran reduced triglyceride amounts through 80% and also decreased the danger of pancreatitis in individuals with relentless chylomicronemia, along with or even without a genetic medical diagnosis.